<DOC>
	<DOCNO>NCT03050593</DOCNO>
	<brief_summary>The investigator wish test hypothesis patient HFpEF different characteristic echo , cardiac MRI plasma protein &amp; chemical profile compare HFrEF healthy volunteer .</brief_summary>
	<brief_title>Developing Imaging And plasMa biOmarkers iN Describing Heart Failure With Preserved Ejection Fraction ( DIAMONDHFpEF )</brief_title>
	<detailed_description>Large scale prospective study incorporate cardiac MRI , echocardiography plasma sample currently lack HFpEF . The main aim study : 1. good phenotype characterise HFpEF ( also compare HFrEF age- sex- match healthy control ) 2. provide mechanistic insight pathophysiology 3. describe potential biomarkers relation relevant clinical outcome ( exercise capacity , heart failure quality life prognosis )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Clinical feature heart failure prior radiographic evidence absence symptom And Either ejection fraction &gt; 50 % ( HFpEF arm ) ejection fraction &lt; 40 % ( HFrEF arm ) Myocardial infarction within precede 6 month Suspected confirm cardiomyopathy ( e.g . hypertrophic , infiltrative ) Suspected confirmed constrictive pericarditis Significant native valve disease ( â‰¥ moderate severity ) Known Significant lung disease ( document FEV1 &lt; 30 % FVC &lt; 50 % ) Noncardiovascular comorbidity likely cause death within 6 month ( e.g . malignancy ) Significant renal failure ( estimate GFR &lt; 30 ml/min/m2 ) Patient inability provide inform consent ( e.g . dementia )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>HFpEF</keyword>
	<keyword>HFrEF</keyword>
</DOC>